ClinicalTrials.gov tag sponsored by:
ClinicalTrials.gov
-
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
scholarlycommons.henryford.com | | Article Details | Related Articles